Dark
Light
System
Institutional Investment Manager
SENZAR ASSET MANAGEMENT, LLC
SENZAR ASSET MANAGEMENT, LLC (CIK: 0001579853) incorporated in Delaware, located at 130 West 19th St., New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q3)
Portfolio Summary: 36 holdings with a total value of $687,471,839.
#
Name
Shares
Value ($)
%
Options
Notes
1 ZOGENIX INC 71,300 962,550 0.14%
2 NEURODERM LTD 56,000 1,157,520 0.17%
3 XOMA CORP DEL 2,327,100 1,749,281 0.25%
4 SIENTRA INC 244,286 2,479,503 0.36%
5 FLUIDIGM CORP DEL COM 310,587 2,518,861 0.37%
6 ALLIQUA BIOMEDICAL INC 921,646 2,921,618 0.42%
7 ARENA PHARMACEUTICALS INC 1,766,991 3,374,953 0.49%
8 RIGEL PHARMACEUTICAL INC 1,375,587 3,397,700 0.49%
9 BIOTA PHARMACEUTIALS INC COM 1,736,400 3,438,072 0.50%
10 MIMEDX GROUP INC COM 416,361 4,017,884 0.58%
11 ACHILLION PHARMACEUTICALS INC COM 619,000 4,277,290 0.62%
12 ORTHOFIX INTERNATIONAL NV 134,984 4,555,710 0.66%
13 Foamix Pharmaceuticals Ltd. 864,408 6,336,111 0.92%
14 DERMIRA INC 295,300 6,892,302 1.00%
15 ACORDA THERAPEUTICS 264,753 7,018,602 1.02%
16 XENOPORT INC 2,150,090 7,460,812 1.09%
17 TANDEM DIABETES CARE INC 865,649 7,626,368 1.11%
18 SYNERON MEDICAL LTD ORD SHS 1,191,510 8,519,297 1.24%
19 ANI PHARMACEUTICALS INC COM 270,040 10,669,280 1.55%
20 INSMED INC COM PAR .01 575,407 10,685,308 1.55%
21 CORIUM INTERNATIONAL INC 1,204,721 11,264,141 1.64%
22 SPECTRANETICS CORP 1,022,512 12,055,416 1.75%
23 RETROPHIN INC COM 722,100 14,629,746 2.13%
24 ALDER BIOPHARMACEUTICALS INC 549,900 18,014,724 2.62%
25 INTRA CELLULAR THERAPIES INC COM 556,224 22,271,209 3.24%
26 CIGNA CORPORATION 173,600 23,439,472 3.41%
27 HEALTHWAYS INC 2,119,037 23,563,691 3.43%
28 BIOGEN INC 89,500 26,116,995 3.80%
29 MALLINCKRODT PUB LTD CO SHS 430,200 27,506,988 4.00%
30 AMGEN INC 207,400 28,687,568 4.17%
31 CONCERT PHARMACEUTICALS INC COM 1,645,673 30,889,282 4.49%
32 AETNA INC NEW 493,404 53,983,332 7.85%
33 ST JUDE 870,300 54,907,227 7.99%
34 TEVA PHARMACEUTICAL INDS LTD 1,214,494 68,570,331 9.97%
35 MYLAN N V 1,719,184 69,214,348 10.07%
36 NEVRO CORP 2,205,181 102,298,347 14.88%

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001164691-15-000171, filed 2015.11.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.